Executive Director, Early-Stage Program Team Leader

Benefits

Parental leave

Not verified

Non-birth-parent leave

Not verified

Family-building benefits

• Fertility benefits: Not verified
• Adoption assistance: Not verified
• Surrogacy assistance: Not verified

Mental health support

Not verified

Relocation assistance

Not verified

Childcare support

Not verified

Learning budget

Not verified

Verification

Not verified checked Jun 13, 2026

Salary

$265K-$376K From the posting source

401(k) match

Reported from DOL Form 5500 industry filing (not employer-specific)

Was this benefit information wrong? Tell us.

Market context

U.S. role benchmark (BLS OEWS)

$116,543 U.S. median for this role

Projected growth (BLS Employment Projections)

+9.8% - Much faster than average

175% above the BLS role benchmark for software engineering aggregate.

Matched to SOC 15-1252 - Software Engineering aggregate by role bucket.

Source: U.S. Bureau of Labor Statistics, OEWS, May 2024 and Employment Projections, 2024-2034.

Role

Role function

Engineering From the posting source

Seniority

Staff Plus From the posting source

Schedule

Shift type

Not verified

Weekend work

Not verified

Company

Equity

Offered Verified - SEC 10-K source

Application

Cover letter

Not verified

Assessment

Not verified

Deadline

Not stated

Where they hire

State eligibility is not yet verified.

About this role

Executive Director, Early-Stage Program Team Leader Bothell, Washington, United States Company Overview Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted cancer therapies. We are advancing an innovative portfolio of therapeutics, supported by a leadership team with deep experience in the design, development, and commercialization of cutting-edge therapies, including antibody-drug conjugates. Our pipeline includes varegacestat, an investigational gamma secretase inhibitor for which an NDA has been submitted to the U.S. FDA; IM-1021, a clinical-stage ROR1 ADC; IM-3050, an IND-cleared FAP-targeted radiotherapy; and IM-1617, an IND-cleared solid tumor ADC. We are also advancing a broad portfolio of early-stage ADCs pursuing undisclosed solid tumor targets. Position Overview The Executive Director, Early-Stage Program Team Leader provides enterprise-level leadership for three or more strategically critical early-stage development programs spanning preclinical through early clinical development (Phase I/II). This role is accountable for defining and driving integrated program strategy, ensuring alignment with corporate objectives, portfolio priorities, and long-term value creation. This person will serve as the strategic and operational leader of cross-functional program teams, with authority to drive decisions, manage trade-offs, and escalate key investment considerations to executive governance forums. They will partner closely with senior functional leaders across Research, Clinical Development, CMC, Regulatory, and Commercial to ensure cohesive execution and disciplined portfolio advancement. This role represents the program(s) at executive leadership reviews and plays a key role in shaping portfolio strategy, resource allocation, and development prioritization. Responsibilities Enterprise Program Strategy & Portfolio Leadership - Define and drive integrated, end-to-end program

Read the full description at job-boards.greenhouse.io. FewerJobs shows a preview and links to the original posting.